Both in vitro and in vivo, quercetin was shown to dose-dependently alleviate NAFLD effectively through AMPK-PINK1 Parkin-mediated mitophagy [238,239]. Here, PRKN is linked to metabolic dysfunction-associated steatotic liver disease.